Indianpolis and San Francisco: To produce and develop solutions for farmers is essential to advance agriculture using the power of nature in conjunction with advanced technology and informatics. TeselaGen Biotechnology Inc., and Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), announced they have entered into a collaboration to produce a state-of-the-art biological design automation platform that can speed discovery work.

Vice President, Research and Development, Dow AgroSciences, Daniel R. Kittle, said “TeselaGen has created a powerful suite of tools for DNA design. These tools have the potential to accelerate our discovery efforts focused on providing sustainable solutions to help feed the growing world.”

The private-cloud platform will enable scientists at Dow AgroSciences to advance their research to find new crop protection and seed products at an accelerated pace, with a secure computational environment to design and create molecular biology research information.

“TeselaGen is a platform that automates and optimizes protocol generation for bio manufacturing. This collaboration is a great complement to our previous work in medical and industrial biotechnology. We are very excited to now bring our platform to bear on problems facing farmers,” said Dr. Michael Fero, Chief Executive Officer, TeselaGen.